Lewy body diseases (LBDs) are a class of debilitating neurodegenerative disorders linked to the abnormal aggregation of the ...
Exenatide had no disease-modifying effects in a phase 3 trial Parkinson’s disease, despite earlier evidence from a phase 2 ...
AnaptysBio may have ended last year on a low, but 2025 is looking up with the news that its PD-1 agonist rosnilimab has ...
During a Case-Based Roundtable® event, Thach-Giao Truong, MD, discussed goals and barriers to treatment when using ...
The threat of grapevine pests and diseases is a constant battle, but research driven by the Pierce’s Disease and Glassy-Winged ...
Microbiome as a potential key to better treatment: Clinical study on new therapy for Crohn's disease
A special liquid diet, known as exclusive enteral nutrition, is an essential therapy for Crohn's disease. Patients consume ...
A fungus that has killed millions of bats across North America has arrived in Arizona, state wildlife officials announced on ...
Among patients with clear cell renal cell carcinoma, improved responses were observed with Lenvima plus Welireg versus ...
"Heart failure and kidney failure often go hand in hand," he told Newsweek, adding that the kidneys control the way the body handles salt and water. If they are not getting rid of these substances ...
News Medical on MSN1d
Scottish Medicines Consortium approves Libtayo as second-line treatment for advanced cervical cancerRegeneron UK Limited today announced that the Scottish Medicines Consortium (SMC) has accepted Libtayo® (cemiplimab) for use on the National Health Service as a second-line monotherapy treatment for ...
Dr. Guru P Sonpavde discusses updated data from studies like EV-302 and CheckMate 274 for patients with urothelial cancer at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback